本页面由Tiger Trade Technology Pte. Ltd.提供服务

再鼎医药

20.34
+1.538.13%
盘前19.91-0.4300-2.11%04:01 EDT
成交量:124.58万
成交额:2,526.95万
市值:22.58亿
市盈率:-12.69
高:20.78
开:19.89
低:19.89
收:18.81
52周最高:44.34
52周最低:15.96
股本:1.11亿
流通股本:1.09亿
量比:1.97
换手率:1.14%
股息:- -
股息率:- -
每股收益(TTM):-1.6026
每股收益(LYR):-1.6026
净资产收益率:-22.56%
总资产收益率:-12.16%
市净率:3.16
市盈率(LYR):-12.69

数据加载中...

2025/10/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/07

重要事件披露

Form 8-K - Current report
2025/07/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/06/18

重要事件披露

Form 8-K - Current report